Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/3/19 17:52 | 7/1/19 | ADPT | Health | BioPrd | Biological Products, (No Diag | Cohen Chad M | WA | O | CFO | P | 20 | 20.00 | 0 | 1 | New | 1 | D | ||||||||||||||
7/3/19 17:50 | 7/1/19 | ADPT | Health | BioPrd | Biological Products, (No Diag | Hill Nancy Louise | WA | O | SVP,Oper | P | 224 | 20.00 | 0 | 11 | New | 11 | M | ||||||||||||||
7/2/19 17:13 | 7/1/19 | ADPT | Health | BioPrd | Biological Products, (No Diag | Viking Global Performance LLC | CT | T | P.d | 5,000 | 20.00 | 0 | 250 | 1 | 38,407 | I | |||||||||||||||
7/2/19 17:11 | 7/1/19 | ADPT | Health | BioPrd | Biological Products, (No Diag | Viking Global Investors LP | CT | T | P.d | 5,000 | 20.00 | 0 | 250 | 1 | 38,407 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |